https://ci994inhibitor.com/tre....atments-for-which-qu
Clients were arbitrarily assigned (11) to receive either WBRT (20 Gy in five fractions) or SRS (15 Gy in one fraction). The principal end point had been the price of accrual every month. Secondary feasibility and medical end things included the ratio of accrued subjects to screened subjects. This trial is signed up with ClinicalTrials.gov (number NCT02220491). Causes total, 210 patients had been screened to enrol 22 customers to the trial; 20 customers had been rando
Mi piace
Commento
Condividi
